Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA+ channel feed
One year into clinical hold, FDA has more questions about 'pooled' microbiome therapy
3 years ago
Hoping to expand monkeypox vaccine supply, US paves the way for new route of administration
3 years ago
Civica, Mayo Clinic and others sound off on FDA draft guidance to mitigate drug shortages
3 years ago
Pharma
Manufacturing
To avoid shortage of Merck's diabetes drug, FDA allows higher impurity levels temporarily
3 years ago
Manufacturing
Updated: FDA slaps Amazon with a warning letter for selling OTC mole removal products
3 years ago
Reata’s ‘regulatory concerns’ turn into three-month delay on FDA decision for Friedreich’s ataxia drug
3 years ago
R&D
CorMedix hit with second CRL for antifungal treatment, citing manufacturing and API issues
3 years ago
Manufacturing
With drug pricing almost done, Congress looks to wrap up FDA user fee legislation
3 years ago
Law
AstraZeneca and Daiichi Sankyo sprint to market after FDA clears Enhertu in just two weeks
3 years ago
Pharma
FDA's vaccine adcomm to review first fecal transplant to treat C. difficile infections
3 years ago
Pharma
Pfizer and Myovant’s endometriosis pain drug Myfembree gets another FDA nod
3 years ago
Pharma
Democrats secure support from key senator ahead of potential drug pricing vote
3 years ago
Pharma
Acadia hits another Nuplazid roadblock as the FDA doles out CRL and recommends another trial
3 years ago
Pharma
FDA issues new guidance for changes to disposable manufacturing materials
3 years ago
Manufacturing
Travere fails to convince regulators to consider accelerated approval for a rare kidney disease — again
3 years ago
R&D
CDC, NIH, FDA leaders call for US-based clinical trial of smallpox drug in treating monkeypox
3 years ago
R&D
Coherus pulls first interchangeable biosimilar win for Lucentis copycat
3 years ago
Pharma
Drug promotion enforcement so far similar under new FDA chief, with just 4 letters in first half of 2022
3 years ago
Pharma
Marketing
J&J nabs label expansion for Stelara in pediatric psoriatic arthritis
3 years ago
Pharma
Celyad gets the go-ahead to resume CAR-T trial for colorectal cancer as FDA lifts hold
3 years ago
R&D
Not yet in the clinic, Beam’s base-edited, off-the-shelf CAR-T put on hold
3 years ago
R&D
Cell/Gene Tx
Arcutis pulls in a win for its topical version of an old AstraZeneca drug in plaque psoriasis
3 years ago
Pharma
Senate proposes $16B to fund the next wave of Covid-19 vaccines, therapeutics in 2023
3 years ago
Coronavirus
Warning letter issued to New Jersey generics manufacturer over quality control issues
3 years ago
Pharma
Manufacturing
First page
Previous page
76
77
78
79
80
81
82
Next page
Last page